Direct thrombin inhibitors. [N Engl J Med. 2005] - PubMed

loading

Review Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors. [Am Heart J. 2005]
Review Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Gurm HS, Bhatt DL. Am Heart J. 2005 Jan; 149(1 Suppl):S43-53.
Review [Direct thrombin inhibitors: their role in the treatment of arterial and venous thrombosis]. [Med Clin (Barc). 2001]
Review [Direct thrombin inhibitors: their role in the treatment of arterial and venous thrombosis].
Rocha E, Panizo C, Lecumberri R. Med Clin (Barc). 2001 Jan 20; 116(2):63-74.
Dabigatran: new drug. Continue to use heparin, a better-known option. [Prescrire Int. 2009]
Dabigatran: new drug. Continue to use heparin, a better-known option.
[No authors listed]Prescrire Int. 2009 Jun; 18(101):97-9.
Review Novel constructs for thrombin inhibition. [Am Heart J. 2005]
Review Novel constructs for thrombin inhibition.
Becker RC. Am Heart J. 2005 Jan; 149(1 Suppl):S61-72.
Review [Prevention and treatment of deep vein thrombosis with ximelagatran]. [Dtsch Med Wochenschr. 2004]
Review [Prevention and treatment of deep vein thrombosis with ximelagatran].
Caspary L, Bauersachs R, Brehme S, Creutzig A, Harenberg J, Hoffmann U, Landgraf H, Schellong S. Dtsch Med Wochenschr. 2004 Jul 23; 129(30):1635-40.

Efficacy and safety of novel anticoagulants compared with established agents. [Ther Adv Hematol. 2011]
Efficacy and safety of novel anticoagulants compared with established agents.
Rybak I, Ehle M, Buckley L, Fanikos J. Ther Adv Hematol. 2011 Jun; 2(3):175-95.
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies. [Clin Interv Aging. 2013]
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies.
Amin A. Clin Interv Aging. 2013; 8:75-84. Epub 2013 Jan 22.
Heparin-induced thrombocytopenia in the pediatric population: a review of current literature. [J Pediatr Pharmacol Ther. 2012]
Heparin-induced thrombocytopenia in the pediatric population: a review of current literature.
Vakil NH, Kanaan AO, Donovan JL. J Pediatr Pharmacol Ther. 2012 Jan; 17(1):12-30.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Direct thrombin inhibitors.
Direct thrombin inhibitors.
N Engl J Med. 2005 Sep 8 ;353(10):1028-40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed